Non-biased enrichment does not improve quantitative proteomic delineation of reovirus T3D-infected HeLa cell protein alterations

Frontiers in Microbiology

Volumn 3, Issue SEP, 2012, Pages

  Jiang, Jieyuan ^a,d   Opanubi, Kolawole J ^a   Coombs, Kevin M ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Bioinformatics; Host cell alterations; Liquid chromatography; Mass spectrometry; RNA virus; Virus infection

Indexed keywords

EID: 84875795470     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00310     Document Type: Article

References (41)

1. Baas, T., Baskin, C. R., Diamond, D. L., Garcia-Sastre, A., Bielefeldt-Ohmann, H., Tumpey, T. M., Thomas, M. J., Carter, V. S., Teal, T. H., Van Hoeven, N., Proll, S., Jacobs, J. M., Caldwell, Z. R., Gritsenko, M. A., Hukkanen, R. R., Camp, D. G. II, Smith, R. D., and Katze, M. G. (2006). Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 80,10813-10828.
2. Berard, A., and Coombs, K. M. (2009). Mammalian reoviruses: propagation, quantification, and storage. Curr. Protoc. Microbiol. Chapter 15, Unit15C.1.
3. Booy, A. T., Haddow, J. D., Ohlund, L. B., Hardie, D. B., and Olafson, R. W. (2005). Application of isotope coded affinity tag (ICAT) analysis for the identification of differentially expressed proteins following infection of Atlantic salmon (Salmo salar) with infectious hematopoi-etic necrosis virus (IHNV) or Reni-bacterium salmoninarum (BKD). J. Proteome Res. 4, 325-334.
4. Burgener, A., Boutilier, J., Wachihi, C., Kimani, J., Carpenter, M., Westma-cott, G., Cheng, K., Ball, T. B., and Plummer, F. (2008). Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J. Proteome Res. 7, 4446-4454.
5. Coffey, M. C., Strong, J. E., Forsyth, P. A., and Lee, P. W. (1998). Reovirus therapy of tumors with activated Ras pathway. Science 282, 1332-1334.
6. Coombs, K. M. (2011). Quantitative proteomics of complex mixtures. Expert Rev. Proteomics 8, 659-677.
7. Coombs, K. M., Berard, A., Xu, W., Krokhin, O., Meng, X., Cortens, J. P., Kobasa, D., Wilkins, J., and Brown, E. G. (2010). Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J. Virol. 84,10888-10906.
8. DeBiasi, R. L., Clarke, P., Meintzer, S., Jotte, R., Kleinschmidt-Demasters, B K., Johnson, G. L., and Tyler, K.L. (2003). Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J. Virol. 77, 8934-8947.
9. Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 4. doi: 10.1186/gb-2003-4-9-r60
10. Dwivedi, R. C., Dhindsa, N., Krokhin, O. V., Cortens, J., Wilkins, J. A., and El-Gabalawy, H. S. (2009). The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients. Arthritis Res. Ther. 11. doi: 10.1186/ar2637
11. Dwivedi, R. C., Spicer, V., Harder, M., Antonovici, M., Ens, W., Standing, K. G., Wilkins, J. A., and Krokhin, O. V. (2008). Practical implementation of 2D HPLC scheme with accurate peptide retention prediction in both dimensions for high-throughput bottom-up proteomics. Anal. Chem. 80, 7036-7042.
12. Forsyth, P., Roldan, G., George, D., Wallace, C., Palmer, C. A., Morris, D., Cairncross, G., Matthews, M. V., Markert, J., Gillespie, Y., Coffey, M., Thompson, B., and Hamilton, M. (2008). A phase I trial of intra-tumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas. Mol. Ther. 16, 627-632.
13. Geiger, T., Wehner, A., Schaab, C., Cox, J., and Mann M. (2012). Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell. Proteomics. PMID: 22278370. [Epub ahead of print].
14. Geiss, G. K., Salvatore, M., Tumpey, T. M., Carter, V. S., Wang, X. Y., Basler, C F., Taubenberger, J. K., Bumgar-ner, R. E., Palese, P., Katze, M. G., and Garcia-Sastre, A. (2002). Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. U.S.A. 99, 10736-10741.
15. Gilar, M., Olivova, P., Daly, A. E., and Gebler, J. C. (2005). Orthogonality of separation in two-dimensional liquid chromatography. Anal. Chem. 77, 6426-6434.
16. Goldberg, A. D., Allis, C. D., and Bernstein, E. (2007). Epigenetics: a landscape takes shape. Cell 128,635-638.
17. Goody, R. J., Beckham, J. D., Rubtsova, K., and Tyler, K. L. (2007). JAK-STAT signaling pathways are activated in the brain following reovirus infection.J. Neurovirol. 13, 373-383.
18. Haller, O., and Kochs, G. (2002). Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3, 710-717.
19. Haller, O., Staeheli, P., and Kochs, G. (2009). Protective role of interferon-induced Mx GTPases against influenza viruses. Rev. Sci. Tech. 28, 219-231.
20. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009a). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4,44-57.
21. Huang, Q. L., Wang, L., Bai, S. Y., Lin, W. S., Chen, W. N., Lin, J. Y., and Lin, X. (2009b). Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2.J. Med. Virol. 81,1539-1550.
22. Jiang, J., Parker, C. E., Fuller, J. R., Kawula, T. H., and Borchers, C. H. (2007). An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularen-sis. Anal. Chim. Acta 605, 70-79.
23. Keshamouni, V G., Jagtap, P., Michai-lidis, G., Strahler, J. R., Kuick, R., Reka, A. K., Papoulias, P., Krish-napuram, R., Srirangam, A., Stan-diford, T. J., Andrews, P. C., and Omenn, G. S. (2009). Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J. Proteome Res. 8, 35-47.
24. Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Kim, J. H., Half-mann, P., Hatta, M., Feldmann, F., Alimonti, J. B., Fernando, L., Li, Y., Katze, M. G., Feldmann, H., and Kawaoka, Y (2007). Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319-323.
25. Lucitt, M. B., Price, T. S., Pizarro, A., Wu, W., Yocum, A. K., Seiler, C., Pack, M. A., Blair, I. A., Fitzgerald, G. A., and Grosser, T. (2008). Analysis of the zebrafish proteome during embryonic development. Mol. Cell Proteomics 7, 981-994.
26. Mendez, II, Hermann, L. L., Hazel-ton, P. R., and Coombs, K. M. (2000). A comparative analysis of freon substitutes in the purification of reovirus and calicivirus. J. Virol. Methods 90, 59-67.
27. Pan, D., Pan, L. Z., Hill, R., Marcato, P., Shmulevitz, M., Vassilev, L. T., and Lee, P. W K. (2011). Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-kappa B activation. Br. J. Cancer 105, 1012-1022.
28. Poggioli, G. J., DeBiasi, R. L., Bickel, R., Jotte, R., Spalding, A., Johnson, G. L., and Tyler, K. L. (2002). Reovirus-induced alterations in gene expression related to cell cycle regulation. J. Virol. 76, 2585-2594.
29. Schiff, L. A., Nibert, M. L., and Tyler, K. L. (2007). Orthoreoviruses and their replication, in Fields Virology, Vol. 5, eds D. M. Knipe and P. M. Howley (Philadelphia: Lippincott Williams &Wilkins), 1853-1915.
30. Sherry, B. (2009). Rotavirus and reovirus modulation of the interferon response. J. Interferon Cytokine Res. 29, 559-567.
31. Skiba, M., Mettenleiter, T. C., and Karger, A. (2008). Quantitative whole-cell proteome analysis of pseudorabies virus-infected cells. J. Virol. 82, 9689-9699.
32. Smith, R. E., Zweerink, H. J., and Joklik, W K. (1969). Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39, 791-810.
33. Spicer, V., Yamchuk, A., Cortens, J., Sousa, S., Ens, W., Standing, K. G., Wilkins, J. A., and Krokhin, O. (2007). Sequence-specific retention calculator. A family of peptide retention time prediction algorithms in reversed-phase HPLC: applicability to various chromatographic conditions and columns. Anal. Chem. 79, 8762-8768.
34. Stewart, J. J., White, J. T.,Yan,X., Collins, S., Drescher, C. W., Urban, N. D., Hood, L., and Lin, B. (2006). Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol. Cell Proteomics 5, 433-443.
35. Thirukkumaran, C. M., Nodwell, M. J., Hirasawa, K., Shi, Z. Q., Diaz, R., Luider, J., Johnston, R. N., Forsyth, P. A., Magliocco, A. M., Lee, P., Nishikawa, S., Donnelly, B., Coffey, M., Trpkov, K., Fonseca, K., Spurrell, J., and Morris, D. G. (2010). Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res. 70, 2435-2444.
36. Tian, Q., Stepaniants, S. B., Mao, M., Weng, L., Feetham, M. C., Doyle, M. J., Yi, E. C., Dai, H., Thorsson, V., Eng, J., Goodlett, D., Berger, J. P., Gunter, B., Linseley, P. S., Stoughton, R. B., Aebersold, R., Collins, S. J., Han-lon, W A., and Hood, L. E. (2004). Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol. Cell Proteomics 3, 960-969.
37. Tran, A. T., and Coombs, K. M. (2006).Reoviruses,in Encyclopedia ofLifeSciences,Vol. 2. (Elsevier). doi: 10.1038/npg.els.0004289
38. Vester, D., Rapp, E., Gade, D., Genzel, Y., and Reichl, U. (2009). Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics 9, 3316-3327.
39. Zhang, J., Niu, D., Sui, J., Ching, C. B., and Chen, W N. (2009). Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: insights on liver angiogenesis. Proteomics 9, 2836-2845.
40. Zolotarjova, N., Mrozinski, P., Chen, H., and Martosella, J. (2008). Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J. Chro-matogr.A 1189,332-338.
41. Zurney, J., Kobayashi, T., Holm, G. H., Dermody, T. S., and Sherry, B. (2009). Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. J. Virol. 83, 2178-2187.